These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 31122207)

  • 21. The effect of p-4E-BP1 and p-eIF4E on cell proliferation in a breast cancer model.
    Pons B; Peg V; Vázquez-Sánchez MA; López-Vicente L; Argelaguet E; Coch L; Martínez A; Hernández-Losa J; Armengol G; Ramon Y Cajal S
    Int J Oncol; 2011 Nov; 39(5):1337-45. PubMed ID: 21750861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of eIF4E and 4EBP1 mRNAs in head and neck cancer.
    Sunavala-Dossabhoy G; Palaniyandi S; Clark C; Nathan CO; Abreo FW; Caldito G
    Laryngoscope; 2011 Oct; 121(10):2136-41. PubMed ID: 21898433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. eIF4E knockdown decreases breast cancer cell growth without activating Akt signaling.
    Soni A; Akcakanat A; Singh G; Luyimbazi D; Zheng Y; Kim D; Gonzalez-Angulo A; Meric-Bernstam F
    Mol Cancer Ther; 2008 Jul; 7(7):1782-8. PubMed ID: 18644990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AKT inhibition overcomes rapamycin resistance by enhancing the repressive function of PRAS40 on mTORC1/4E-BP1 axis.
    Mi W; Ye Q; Liu S; She QB
    Oncotarget; 2015 Jun; 6(16):13962-77. PubMed ID: 25961827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genomic and expression analysis of the 8p11-12 amplicon in human breast cancer cell lines.
    Ray ME; Yang ZQ; Albertson D; Kleer CG; Washburn JG; Macoska JA; Ethier SP
    Cancer Res; 2004 Jan; 64(1):40-7. PubMed ID: 14729606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human Merkel cell polyomavirus small T antigen is an oncoprotein targeting the 4E-BP1 translation regulator.
    Shuda M; Kwun HJ; Feng H; Chang Y; Moore PS
    J Clin Invest; 2011 Sep; 121(9):3623-34. PubMed ID: 21841310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphorylated 4E binding protein 1: a hallmark of cell signaling that correlates with survival in ovarian cancer.
    Castellvi J; Garcia A; Rojo F; Ruiz-Marcellan C; Gil A; Baselga J; Ramon y Cajal S
    Cancer; 2006 Oct; 107(8):1801-11. PubMed ID: 16983702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adaptation to mTOR kinase inhibitors by amplification of eIF4E to maintain cap-dependent translation.
    Cope CL; Gilley R; Balmanno K; Sale MJ; Howarth KD; Hampson M; Smith PD; Guichard SM; Cook SJ
    J Cell Sci; 2014 Feb; 127(Pt 4):788-800. PubMed ID: 24363449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concurrent inhibition of PI3-kinase and mTOR induces cell death in diffuse large B cell lymphomas, a mechanism involving down regulation of Mcl-1.
    Zang C; Eucker J; Liu H; Müller A; Possinger K; Scholz CW
    Cancer Lett; 2013 Oct; 339(2):288-97. PubMed ID: 23200668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of 4E-BP1 function induces EMT and promotes cancer cell migration and invasion via cap-dependent translational activation of snail.
    Cai W; Ye Q; She QB
    Oncotarget; 2014 Aug; 5(15):6015-27. PubMed ID: 24970798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers.
    Zhou X; Tan M; Stone Hawthorne V; Klos KS; Lan KH; Yang Y; Yang W; Smith TL; Shi D; Yu D
    Clin Cancer Res; 2004 Oct; 10(20):6779-88. PubMed ID: 15501954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypoxia inhibits protein synthesis through a 4E-BP1 and elongation factor 2 kinase pathway controlled by mTOR and uncoupled in breast cancer cells.
    Connolly E; Braunstein S; Formenti S; Schneider RJ
    Mol Cell Biol; 2006 May; 26(10):3955-65. PubMed ID: 16648488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis.
    Nagalingam A; Arbiser JL; Bonner MY; Saxena NK; Sharma D
    Breast Cancer Res; 2012 Feb; 14(1):R35. PubMed ID: 22353783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mammalian target of rapamycin (mTOR) activity dependent phospho-protein expression in childhood acute lymphoblastic leukemia (ALL).
    Nemes K; Sebestyén A; Márk A; Hajdu M; Kenessey I; Sticz T; Nagy E; Barna G; Váradi Z; Kovács G; Kopper L; Csóka M
    PLoS One; 2013; 8(4):e59335. PubMed ID: 23573198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Translation control during prolonged mTORC1 inhibition mediated by 4E-BP3.
    Tsukumo Y; Alain T; Fonseca BD; Nadon R; Sonenberg N
    Nat Commun; 2016 Jun; 7():11776. PubMed ID: 27319316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. eIF4E is a critical regulator of human papillomavirus (HPV)-immortalized cervical epithelial (H8) cell growth induced by nicotine.
    Chen L; Wang H
    Toxicology; 2019 May; 419():1-10. PubMed ID: 30836163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive profiling of 8p11-12 amplification in breast cancer.
    Gelsi-Boyer V; Orsetti B; Cervera N; Finetti P; Sircoulomb F; Rougé C; Lasorsa L; Letessier A; Ginestier C; Monville F; Esteyriès S; Adélaïde J; Esterni B; Henry C; Ethier SP; Bibeau F; Mozziconacci MJ; Charafe-Jauffret E; Jacquemier J; Bertucci F; Birnbaum D; Theillet C; Chaffanet M
    Mol Cancer Res; 2005 Dec; 3(12):655-67. PubMed ID: 16380503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiR-99a antitumor activity in human breast cancer cells through targeting of mTOR expression.
    Hu Y; Zhu Q; Tang L
    PLoS One; 2014; 9(3):e92099. PubMed ID: 24637915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple interacting oncogenes on the 8p11-p12 amplicon in human breast cancer.
    Yang ZQ; Streicher KL; Ray ME; Abrams J; Ethier SP
    Cancer Res; 2006 Dec; 66(24):11632-43. PubMed ID: 17178857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amplification of WHSC1L1 regulates expression and estrogen-independent activation of ERα in SUM-44 breast cancer cells and is associated with ERα over-expression in breast cancer.
    Irish JC; Mills JN; Turner-Ivey B; Wilson RC; Guest ST; Rutkovsky A; Dombkowski A; Kappler CS; Hardiman G; Ethier SP
    Mol Oncol; 2016 Jun; 10(6):850-65. PubMed ID: 27005559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.